Greater LA Kellogg Healthcare Alumni Event
Please join us on Thursday, May 30 from 5:30 to 7:30 pm
Please join Professor Craig Garthwaite, Casey Logan, Chief Business Officer at Travere Therapeutics and your fellow Kellogg classmates and alumni for an evening of networking and discussion. Professor Garthwaite examines the business impacts of healthcare policies, and his research provides insights on pricing, innovation, market influences and more. Casey has led business development and strategic planning activities in the highly competitive and innovation-driven pharmaceutical industry. They will discuss a wide range of topics such as how to fund medical technology and innovation as part of a growth strategy, including growing through acquisitions. This event will include time for networking and conversation; food and drinks will be served. We hope you can join us. Register here.
Casey Logan is chief business officer and a member of the executive team at Travere Therapeutics. He is responsible for leading corporate development, strategic planning, program management and information technology at Travere. Prior to Travere Therapeutics in 2018, he served as chief business officer at Tracon Pharmaceuticals, an oncology-focused drug development company. At Tracon, Mr. Logan led all strategic, business and corporate development efforts, including the company’s IPO in January 2015. Before joining Tracon, Mr. Logan held senior corporate development roles at biopharmaceutical companies Bird Rock Bio (formerly RuiYi, Inc.) and Anadys Pharmaceuticals, Inc., before its acquisition by Roche. Prior to these roles, Mr. Logan was a member of the corporate business development group at Eli Lilly and Company. Mr. Logan served as an officer in the US Naval Nuclear Propulsion Program. He received his bachelor’s of science in chemical engineering from the University of Michigan, and a master’s in business administration from the Kellogg School of Management at Northwestern University.